2YP.F - Health Catalyst, Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
276,236
276,236
241,926
188,845
154,941
Cost of Revenue
143,049
143,049
124,354
98,077
75,345
Gross Profit
133,187
133,187
117,572
90,768
79,596
Operating Expenses
Research Development
75,680
75,680
62,733
53,517
46,252
Selling General and Administrative
149,215
149,215
160,961
114,651
78,997
Total Operating Expenses
273,192
273,192
261,222
186,893
134,461
Operating Income or Loss
-140,005
-140,005
-143,650
-96,125
-54,865
Interest Expense
7,239
1,678
16,458
11,572
3,419
Total Other Income/Expenses Net
-126
-126
24
-8,514
-1,670
Income Before Tax
-141,683
-141,683
-160,108
-116,211
-59,954
Income Tax Expense
-4,280
-4,280
-6,898
-1,194
142
Income from Continuing Operations
-137,403
-137,403
-153,210
-115,017
-60,096
Net Income
-137,403
-137,403
-153,210
-115,017
-60,096
Net Income available to common shareholders
-137,403
-137,403
-153,210
-115,017
-240,922
Basic EPS
-
-2.56
-3.23
-2.91
-12.86
Diluted EPS
-
-2.63
-3.23
-2.91
-12.86
Basic Average Shares
-
53,722
47,495
39,541
18,741
Diluted Average Shares
-
54,080
47,495
39,541
18,741
EBITDA
-
-91,708
-106,122
-85,914
-47,323